Loading…
immunitoAI is a TechBio company that develops antibody therapeutics using its proprietary AI platform, AbInitio. The company designs novel biological drugs tailored to specific protein targets and drug characteristics for clinical applications.
AI named immunitoAI in June 2026.
AI cited immunitoai.com in these answers, after absci.com, axios.com, and biology.digital.
immunitoai.com 17%Other sites 83%